Exposure-related health effects of silver and silver compounds: A review

被引:522
作者
Drake, PL [1 ]
Hazelwood, KJ [1 ]
机构
[1] NIOSH, Spokane Res Lab, Spokane, WA 99207 USA
关键词
argyria; argyrosis; occupational exposure; occupational exposure limits; silver;
D O I
10.1093/annhyg/mei019
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A critical review of studies examining exposures to the various forms of silver was conducted to determine if some silver species are more toxic than others. The impetus behind conducting this review is that several occupational exposure limits and guidelines exist for silver, but the values for each depend on the form of silver as well as the individual agency making the recommendations. For instance, the American Conference of Governmental Industrial Hygienists has established separate threshold limit values for metallic silver (0.1 mg/m(3)) and soluble compounds of silver (0.01 mg/m(3)). On the other hand, the permissible exposure limit (PEL) recommended by the Occupational Safety and Health Administration and the Mine Safety and Health Administration and the recommended exposure limit set by the National Institute for Occupational Safety and Health is 0.01 mg/m(3) for all forms of silver. The adverse effects of chronic exposure to silver are a permanent bluish-gray discoloration of the skin (argyria) or eyes (argyrosis). Most studies discuss cases of argyria and argyrosis that have resulted primarily from exposure to the soluble forms of silver. Besides argyria and argyrosis, exposure to soluble silver compounds may produce other toxic effects, including liver and kidney damage, irritation of the eyes, skin, respiratory, and intestinal tract, and changes in blood cells. Metallic silver appears to pose minimal risk to health. The current occupational exposure limits do not reflect the apparent difference in toxicities between soluble and metallic silver; thus, many researchers have recommended that separate PELs be established.
引用
收藏
页码:575 / 585
页数:11
相关论文
共 93 条
  • [1] ARGYRIA - TISSUE DEPOSITION OF SILVER AS SELENIDE
    AASETH, J
    OLSEN, A
    HALSE, J
    HOVIG, T
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1981, 41 (03) : 247 - 251
  • [2] ACGIH, 1991, DOC THRESH LIM VAL B
  • [3] *ACGIH, 2001, S 6 EDN CIN OH AM C
  • [4] [Anonymous], 2001, HAWLEYS CONDENSED CH
  • [5] The determination of silver in whole blood and its application to biological monitoring of occupationally exposed groups
    Armitage, SA
    White, MA
    Wilson, HK
    [J]. ANNALS OF OCCUPATIONAL HYGIENE, 1996, 40 (03) : 331 - 338
  • [6] *ATSDR, 1990, TP9024 AG TOX SUBST
  • [7] EFFECTS OF SILVER IN ISOLATED RAT HEPATOCYTES
    BALDI, C
    MINOIA, C
    DINUCCI, A
    CAPODAGLIO, E
    MANZO, L
    [J]. TOXICOLOGY LETTERS, 1988, 41 (03) : 261 - 268
  • [8] BARRIE HJ, 1947, BRIT J IND MED, V4, P225
  • [9] BERRY JP, 1982, PATHOL BIOL, V30, P136
  • [10] Argyria
    Bouts, BA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (20) : 1554 - 1554